Araştırma Makalesi

Maternal plasma Elabela levels in intrauterine growth restriction

Cilt: 46 Sayı: 4 30 Aralık 2021
PDF İndir
EN TR

Maternal plasma Elabela levels in intrauterine growth restriction

Öz

Purpose: The aim of this study was to investigate the role of Elabela in the etiopathogenesis of intrauterine growth retardation (IUGR). Materials and Methods: The present prospective study included 43 healthy pregnant women and 46 pregnant women with IUGR. Maternal serum were collected from the control group and IUGR group at time of delivery. Elabela levels were analyzed in maternal serum through ELISA method. Results: Lower Elabela levels (IUGR: 1.09 (0.61-15.61) ng / mL and Control: 1.44 (0.37-31.33) ng / mL) were observed in IUGR patients compared to controls. Elabela levels were positively correlated with gestational week and neonatal weight. (r = 0.263, p = 0.013 and r = 0.259, respectively; p = 0.014). Conclusion: The present study serves as the first study revealing the role of the decrease in Elabela in maternal serum on the etiopathogenesis of IUGR. This suggests that Elabela could be a potential drug target in cases with IUGR.

Anahtar Kelimeler

intrauterine growth restriction, Elabela, Pregnancy

Kaynakça

  1. 1. Figueras F, Gratacos E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther 2014;36(2):86–98.
  2. 2. Hui L, Challis D. Diagnosis and management of fetal growth restriction: the role of fetal therapy. Best Pract Res Clin Obstet Gynaecol 2008;22(1):139–58.
  3. 3. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction–part 1. J Maternfetal Neonat Med 2016;29(24):3977–87.
  4. 4. Kesavan K, Devaskar SU. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatr Clin North Am 2019;66(2):403-23.
  5. 5. Suhag A, Berghella V. Intrauterine growth restriction (IUGR): etiology and diagnosis. Curr Obstet Gynecol Rep 2013;2:102–11.
  6. 6. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195(1):40–9.
  7. 7. Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R, et al. Elabela- apelin receptor signaling pathway is functional in mammalian systems. Sci Rep 2015;5:8170.
  8. 8. Chng SC, Ho L, Tian J, Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Developmental cell 2013;27(6):672-80.
  9. 9. Devic E, Rizzoti K, Bodin S, Knibiehlern B, Audigier Y. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech. Dev 1999;84(1–2):199–203.
  10. 10. Helker C.S, Schuermann A, Pollmann C, Chng SC, Kiefer F, Reversadeet B, al. The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis. Elife 2015;4:e06726. doi: 10.7554/eLife.06726.

Kaynak Göster

APA
Alkan Baylan, F., & Karaküçük, S. (2021). Maternal plasma Elabela levels in intrauterine growth restriction. Cukurova Medical Journal, 46(4), 1344-1350. https://doi.org/10.17826/cumj.976828
AMA
1.Alkan Baylan F, Karaküçük S. Maternal plasma Elabela levels in intrauterine growth restriction. Cukurova Med J. 2021;46(4):1344-1350. doi:10.17826/cumj.976828
Chicago
Alkan Baylan, Filiz, ve Selim Karaküçük. 2021. “Maternal plasma Elabela levels in intrauterine growth restriction”. Cukurova Medical Journal 46 (4): 1344-50. https://doi.org/10.17826/cumj.976828.
EndNote
Alkan Baylan F, Karaküçük S (01 Aralık 2021) Maternal plasma Elabela levels in intrauterine growth restriction. Cukurova Medical Journal 46 4 1344–1350.
IEEE
[1]F. Alkan Baylan ve S. Karaküçük, “Maternal plasma Elabela levels in intrauterine growth restriction”, Cukurova Med J, c. 46, sy 4, ss. 1344–1350, Ara. 2021, doi: 10.17826/cumj.976828.
ISNAD
Alkan Baylan, Filiz - Karaküçük, Selim. “Maternal plasma Elabela levels in intrauterine growth restriction”. Cukurova Medical Journal 46/4 (01 Aralık 2021): 1344-1350. https://doi.org/10.17826/cumj.976828.
JAMA
1.Alkan Baylan F, Karaküçük S. Maternal plasma Elabela levels in intrauterine growth restriction. Cukurova Med J. 2021;46:1344–1350.
MLA
Alkan Baylan, Filiz, ve Selim Karaküçük. “Maternal plasma Elabela levels in intrauterine growth restriction”. Cukurova Medical Journal, c. 46, sy 4, Aralık 2021, ss. 1344-50, doi:10.17826/cumj.976828.
Vancouver
1.Filiz Alkan Baylan, Selim Karaküçük. Maternal plasma Elabela levels in intrauterine growth restriction. Cukurova Med J. 01 Aralık 2021;46(4):1344-50. doi:10.17826/cumj.976828